Measuring and Analyzing Length of Stay in Critical Care Trials

Medical Care

Volumn 57, Issue 9, 2019, Pages E53-E59

  Harhay, Michael O ^a   Ratcliffe, Sarah J ^c   Small, Dylan S ^b,d   Suttner, Leah H ^a   Crowther, Michael J ^e   Halpern, Scott D ^a,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f and Critical Care Medicine

Author keywords

bias; endpoints; epidemiology; length of stay; outcomes; RCT

Indexed keywords

ARTICLE; CRITICALLY ILL PATIENT; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIMULATION; SURVIVAL; DATA ANALYSIS; HOSPITAL MORTALITY; PROCEDURES;

CRITICAL CARE; DATA ANALYSIS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 85060380586     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000001059     Document Type: Article

References (35)

1. Hernán MA, Robins JM. Causal Inference. Boca Raton, FL: Chapman &Hall/CRC; 2019. (forthcoming).
2. McConnell S, Stuart EA, Devaney B. The truncation-by-death problem: what to do in an experimental evaluation when the outcome is not always defined. Eval Rev. 2008;32:157-186.
3. Kurland BF, Johnson LL, Egleston BL, et al. Longitudinal data with follow-up truncated by death: match the analysis method to research aims. Stat Sci. 2009;24:211-222.
4. Brock GN, Barnes C, Ramirez JA, et al. How to handle mortality when investigating length of hospital stay and time to clinical stability. BMC Med Res Methodol. 2011;11:144.
5. Yang F, Small DS. Using post-quality of life measurement information in censoring by death problems. JRSSB. 2016;78:299-318.
6. Chiba Y, VanderWeele TJ. A simple method for principal strata effects when the outcome has been truncated due to death. Am J Epidemiol. 2011;173:745-751.
7. Hayden D, Pauler DK, Schoenfeld D. An estimator for treatment comparisons among survivors in randomized trials. Biometrics. 2005;61:305-310.
8. Checkley W, Brower RG, Munoz A, et al. Inference for mutually exclusive competing events through a mixture of generalized gamma distributions. Epidemiology. 2010;21:557-565.
9. Wang C, Scharfstein DO, Colantuoni E, et al. Inference in randomized trials with death and missingness. Biometrics. 2017;73:431-440.
10. Schoenfeld DA, Bernard GR, Network A. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30:1772-1777.
11. Colantuoni E, Scharfstein DO, Wang C, et al. Statistical methods to compare functional outcomes in randomized controlled trials with high mortality. BMJ. 2018;360:j5748.
12. Deslandes E, Chevret S. Joint modeling of multivariate longitudinal data and the dropout process in a competing risk setting: application to ICU data. BMC Med Res Methodol. 2010;10:69.
13. Colantuoni E, Dinglas VD, Ely EW, et al. Statistical methods for evaluating delirium in the ICU. Lancet Respir Med. 2016;4:534-536.
14. Harhay MO, Wagner J, Ratcliffe SJ, et al. Outcomes and statistical power in adult critical care randomized trials. Am J Respir Crit Care Med. 2014;189:1469-1478.
15. Crowther MJ, Lambert PC. Simulating complex survival data. Stata J. 2012;12:674-687.
16. Allignol A, Schumacher M, Wanner C, et al. Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011;11:86.
17. Beyersmann J, Latouche A, Buchholz A, et al. Simulating competing risks data in survival analysis. Stat Med. 2009;28:956-971.
18. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363:1107-1116.
19. Moitra VK, Guerra C, Linde-Zwirble WT, et al. Relationship between ICU length of stay and long-term mortality for elderly ICU survivors. Crit Care Med. 2016;44:655-662.
20. Lin W, Halpern SD, Prasad Kerlin M, et al. A "placement of death" approach for studies of treatment effects on ICU length of stay. Stat Methods Med Res. 2017;26:292-311.
21. Kerlin MP, Small DS, Cooney E, et al. A randomized trial of nighttime physician staffing in an intensive care unit. N Engl J Med. 2013;368: 2201-2209.
22. Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506-517.
23. Ali NA, Hammersley J, Hoffmann SP, et al. Continuity of care in intensive care units: a cluster-randomized trial of intensivist staffing. Am J Respir Crit Care Med. 2011;184:803-808.
24. Ridgeon EE, Young PJ, Bellomo R, et al. The fragility index in multicenter randomized controlled critical care trials. Crit Care Med. 2016;44:1278-1284.
25. Brown SE, Ratcliffe SJ, Halpern SD. An empirical derivation of the optimal time interval for defining ICU readmissions. Med Care. 2013;51: 706-714.
26. Harhay MO, Ratcliffe SJ, Halpern SD. Measurement error due to patient flow in estimates of intensive care unit length of stay. Am J Epidemiol. 2017;186:1389-1395.
27. Aalen OO, Cook RJ, Roysland K. Does Cox analysis of a randomized survival study yield a causal treatment effect? Lifetime Data Anal. 2015;21:579-593.
28. Aberegg SK, Richards DR, O'Brien JM. Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care. 2010;14:R77.
29. Latronico N, Metelli M, Turin M, et al. Quality of reporting of randomized controlled trials published in Intensive Care Medicine from 2001 to 2010. Intensive Care Med. 2013;39:1386-1395.
30. Iwashyna TJ, Burke JF, Sussman JB, et al. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192: 1045-1051.
31. Lagakos SW. General right censoring and its impact on the analysis of survival data. Biometrics. 1979;35:139-156.
32. Tsiatis AA, Davidian M. An overview of joint modeling of longitudinal and time-to-event data. Stat Sin. 2004;14:809-834.
33. Blackwood B, Clarke M, McAuley DF, et al. How outcomes are defined in clinical trials of mechanically ventilated adults and children. Am J Respir Crit Care Med. 2014;189:886-893.
34. Hirsch BR, Califf RM, Cheng SK, et al. Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med. 2013;173:972-979.
35. Williamson PR, Altman DG, Blazeby JM, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132.